SMN1 and spinal muscular atrophy: In one famous example, multiple studies have shown that replacing SMN1 gene in treating spinal muscular atrophy (an approved gene replacement therapy indication 5 years ago) exhibited the gain of toxic function by long-term sustained overexpression of neuronal proteins SMN in the sensorimotor circuit, which is not due to the use of AAV vectors48,49.